Edition:
India

Suven Life Sciences Ltd (SUVP.NS)

SUVP.NS on National Stock Exchange of India

199.15INR
16 Jan 2018
Change (% chg)

Rs-8.20 (-3.95%)
Prev Close
Rs207.35
Open
Rs207.00
Day's High
Rs209.00
Day's Low
Rs198.05
Volume
304,279
Avg. Vol
530,143
52-wk High
Rs230.40
52-wk Low
Rs155.00

Latest Key Developments (Source: Significant Developments)

Suven Life Sciences Secures Product Patents In Canada, India
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Suven Life Sciences Ltd ::‍SAYS SECURES PRODUCT PATENTS IN CANADA AND INDIA.SAYS PATENT CORRESPONDING TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES.SAYS CANADA AND INDIA PATENTS ARE VALID THROUGH 2034 AND 2028 ‍​RESPECTIVELY.  Full Article

India's Suven Life Sciences gets product patent in Singapore
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Suven Life Sciences Ltd :Gets product patent from Singapore related to new chemical entities for treating disorders associated with neurodegenerative diseases.  Full Article

Suven Life Sciences gets product patent in New Zealand​
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Suven Life Sciences Ltd :Says ‍co secures a product patent in New Zealand​.Says patents are valid through 2034.Product patent corresponds to New Chemical Entities (NCEs) for treatment of disorders associated with neurodegenerative diseases‍​‍​.  Full Article

Suven Life Sciences secures product patents in Israel, Macau and South Korea
Monday, 10 Jul 2017 

July 10 (Reuters) - Suven Life Sciences Ltd ::Says ‍'suven Life Sciences secures product patents in Israel, Macau and South Korea'.​.Says grant of 1 product patent from Israel, 1 product patent from Macau , 1 product patent from South Korea.Suven life sciences says patents of products intended for treatment of disorders related to neurodegenerative diseases; patents valid through 2032.  Full Article

Suven Life Sciences' Pashamylarams Unit successfully completes USFDA inspection
Thursday, 21 Jul 2016 

Suven Life Sciences Ltd : Co's pashamylarams unit successfully completes US FDA inspection; gets eir for pashamylarams unit .  Full Article

Suven Life Sciences gets 2 product patents in India, South Africa
Tuesday, 12 Jul 2016 

Suven Life Sciences Ltd : Suven Life Sciences secures two (2) product patents in India and South Africa .  Full Article

Suven Life Sciences gets two product patents in Canada and Hong Kong
Tuesday, 14 Jun 2016 

Suven Life Sciences Ltd : Suven Life Sciences secures two product patents in Canada and Hong Kong . Patents for treatment of disorders associated with neurodegenerative diseases; patents are valid through 2032 and 2030 respectively .  Full Article

Suven Life Sciences gets 2 product patents in Israel and Mexico
Friday, 3 Jun 2016 

Suven Life Sciences Ltd : Suven Life Sciences secures two (2) product patents in Israel and Mexico .  Full Article

Suven Life Sciences secures two product patents in Australia and Canada
Friday, 19 Feb 2016 

Suven Life Sciences Ltd:Suven Life Sciences secures two product patents in Australia and Canada.  Full Article

BRIEF-Suven Life Sciences Secures Product Patents In Canada, India

* SAYS PATENT CORRESPONDING TO NEW CHEMICAL ENTITIES (NCES) FOR TREATMENT OF DISORDERS ASSOCIATED WITH NEURODEGENERATIVE DISEASES